TipRanks
Go Ultimate55% OFF

Eli Lilly & Co (LLY) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Florbetapir F18, Florbetaben F 18, Ly4560736Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid, PlasmaPhase INot Yet RecruitingA Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)Sep 22, 2026
Donanemab, Ly3002813Alzheimer DiseasePhase IVNot Yet RecruitingA Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's DiseaseSep 18, 2026―
Vepugratinib, Ly3866288Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3Phase IINot Yet RecruitingA Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial CancerSep 15, 2026
SelpercatinibCarcinoma, Non-small-cell Lung, Thyroid NeoplasmsPhase IVNot Yet RecruitingA Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in IndiaSep 11, 2026
TirzepatideObesityPhase IIINot Yet RecruitingEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)Sep 09, 2026
Oxaliplatin, Cetuximab, 5-Fluorouracil, Olomorasib, Leucovorin/Levofolinate Calcium, Ly3537982Colorectal NeoplasmsPhase IINot Yet RecruitingA Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationSep 04, 2026―
Ly4329090Obesity, OverweightPhase IRecruitingA Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise HealthySep 03, 2026
Combined Oral Contraceptive, Eloralintide, Ly3841136Obesity, OverweightPhase IRecruitingA Study of Eloralintide (LY3841136) in Female Participants With Obesity or OverweightSep 03, 2026
Tirzepatide, AcetaminophenObesity, Overweight, Diabetes Mellitus, Type 1Phase IRecruitingA Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesitySep 01, 2026
Ly5625575Healthy Volunteers, C-Reactive ProteinPhase IRecruitingA Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)Aug 31, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly And Company (MX:LLY) have in its pipeline
Eli Lilly & Co MX:LLY is currently developing the following drugs: Florbetapir F18, Florbetaben F 18, Ly4560736, Donanemab, Ly3002813, Vepugratinib, Ly3866288, Selpercatinib, Tirzepatide, Oxaliplatin, Cetuximab, 5-Fluorouracil, Olomorasib, Leucovorin/Levofolinate Calcium, Ly3537982, Ly4329090, Combined Oral Contraceptive, Eloralintide, Ly3841136, Tirzepatide, Acetaminophen, Ly5625575, Abemaciclib Tablet, Abemaciclib Oral Granules, Orforglipron, Ly3502970, Florbetapir F18, Ly4405094, Florbetaben F 18, Clazakizumab, Brenipatide, Ly3537031, Eloralintide, Macupatide, Ly3532226, Midazolam, Ly4355756, Standard Of Care, Ly3537031, Brenipatide, Acetaminophen, Eloralintide, Ly3841136, Ly4268989, Eloralintide, Ly3841136, Ly4178256, Dulaglutide, Orforglipron, Ly3502970, High-Fat Meal, Tersolisib, Low-Fat Meal, Ly4064809, Ly4174794, Ly4065967, Lepodisiran, Ly3819469, Mirikizumab, Ly3074828, Ly4065967 Tablet, Ly4065967 Formulated Capsule, Ly4065967 Capsule, Donanemab, Ly3439539, Itraconazole, Ly4395089, Eloralintide, Macupatide, Ly3841136, Ly3532226, Ly4256984. These drug candidates are in various stages of clinical development as the company works toward FDA approval.